SymBio Pharmaceuticals Limited

TSE:4582 Stock Report

Market Cap: JP¥11.7b

SymBio Pharmaceuticals Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for SymBio Pharmaceuticals.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth11.7%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

We're Hopeful That SymBio Pharmaceuticals (TSE:4582) Will Use Its Cash Wisely

Sep 24
We're Hopeful That SymBio Pharmaceuticals (TSE:4582) Will Use Its Cash Wisely

SymBio Pharmaceuticals Limited's (TSE:4582) 31% Share Price Surge Not Quite Adding Up

Aug 06
SymBio Pharmaceuticals Limited's (TSE:4582) 31% Share Price Surge Not Quite Adding Up

Why Investors Shouldn't Be Surprised By SymBio Pharmaceuticals Limited's (TSE:4582) 28% Share Price Surge

Jun 11
Why Investors Shouldn't Be Surprised By SymBio Pharmaceuticals Limited's (TSE:4582) 28% Share Price Surge

Here's Why We're Watching SymBio Pharmaceuticals' (TYO:4582) Cash Burn Situation

Feb 09
Here's Why We're Watching SymBio Pharmaceuticals' (TYO:4582) Cash Burn Situation

If You Had Bought SymBio Pharmaceuticals' (TYO:4582) Shares Five Years Ago You Would Be Down 58%

Dec 18
If You Had Bought SymBio Pharmaceuticals' (TYO:4582) Shares Five Years Ago You Would Be Down 58%

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as SymBio Pharmaceuticals has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

TSE:4582 - Analysts future estimates and past financials data (JPY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/20243,067-4,019N/AN/AN/A
6/30/20243,695-3,424-1,349-1,105N/A
3/31/20244,642-2,743N/AN/AN/A
12/31/20235,589-1,962-426-194N/A
9/30/20237,074-1,164N/AN/AN/A
6/30/20238,313-8181228N/A
3/31/20239,2371,020N/AN/AN/A
12/31/202210,0081,1791,5671,614N/A
9/30/202210,0593,262N/AN/AN/A
6/30/20229,9833,3462,7002,763N/A
3/31/20229,1522,405N/AN/AN/A
12/31/20218,2572,03276140N/A
9/30/20216,208-1,071N/AN/AN/A
6/30/20214,773-2,411-4,067-3,990N/A
3/31/20213,856-3,308N/AN/AN/A
12/31/20202,987-4,090-4,271-4,122N/A
9/30/20203,162-3,430N/AN/AN/A
6/30/20202,193-4,191-5,026-4,847N/A
3/31/20201,778-4,751N/AN/AN/A
12/31/20192,838-4,376-4,567-4,351N/A
9/30/20192,811-4,452N/AN/AN/A
6/30/20193,912-3,434-2,148-2,024N/A
3/31/20194,559-2,610N/AN/AN/A
12/31/20183,836-2,753-2,364-2,325N/A
9/30/20184,060-2,373N/AN/AN/A
6/30/20183,587-4,100N/A-4,368N/A
3/31/20183,463-4,155N/AN/AN/A
12/31/20173,444-3,978N/A-3,817N/A
9/30/20173,377-3,943N/AN/AN/A
6/30/20172,943-2,404N/A-2,093N/A
3/31/20173,045-2,243N/AN/AN/A
12/31/20162,368-2,313N/A-1,960N/A
9/30/20162,008-3,488N/AN/AN/A
6/30/20162,168-3,131N/A-2,488N/A
3/31/20161,718-2,864N/AN/AN/A
12/31/20151,933-2,632N/A-2,272N/A
9/30/20151,939-1,232N/AN/AN/A
6/30/20151,956-1,077N/A-951N/A
3/31/20152,190-1,082N/AN/AN/A
12/31/20141,955-1,116N/A-1,266N/A
9/30/20141,557-1,358N/AN/AN/A
6/30/20141,697-1,506N/A-1,542N/A
3/31/20141,217-1,707N/AN/AN/A
12/31/20131,532-1,605N/A-1,677N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 4582's forecast earnings growth is above the savings rate (0.3%).

Earnings vs Market: Insufficient data to determine if 4582's earnings are forecast to grow faster than the JP market

High Growth Earnings: Insufficient data to determine if 4582's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 4582's revenue is forecast to grow faster than the JP market.

High Growth Revenue: Insufficient data to determine if 4582's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 4582's Return on Equity is forecast to be high in 3 years time


Discover growth companies